pomegranate glp-1 Health – GLP1 Match Pomegranate Nature’s GLP-1 (Ozempic), Scientists
Description
As we look to 2026, the story becomes one of defining firsts: the debut of oral GLP-1s, the first loss of exclusivity for a GLP-1 receptor antagonist, and landmark coverage decisions such as obesity medications entering Medicare formularies for obesity as a standalone indication
It uses natural bioactive peptides and polyphenols, delivered orally as a nutraceutical, primarily for fat loss and appetite control
This variability could have impacted the consistency of the results and the overall interpretation of gastrointestinal adverse events
doi: 10.1007/s00125-023-05906-7
